Literature DB >> 20357057

Positive deamidated gliadin peptide antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy.

Miriam Parizade1, Bracha Shainberg.   

Abstract

Reports from our clinical laboratory database show that 75% of children <2 years old tested for celiac serology who were found positive for deamidated gliadin peptide (DGP) antibodies had negative results for tissue transglutaminase IgA. DGP levels were shown to decline and disappear without a gluten-free diet. This observation questions DGP's specificity for diagnosis of celiac disease.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20357057      PMCID： PMC2863389          DOI： 10.1128/CVI.00425-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  19 in total

Review 1.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists.

Authors:  G Oberhuber; G Granditsch; H Vogelsang
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-10       Impact factor: 2.566

2.  Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.

Authors:  Harry E Prince
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 3.  American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.

Authors:  Alaa Rostom; Joseph A Murray; Martin F Kagnoff
Journal:  Gastroenterology       Date:  2006-12       Impact factor: 22.682

4.  Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.

Authors:  Edwin Liu; Marcella Li; Lisa Emery; Iman Taki; Kathy Barriga; Claudio Tiberti; George S Eisenbarth; Marian J Rewers; Edward J Hoffenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-09       Impact factor: 2.839

5.  Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

Authors:  Shadi Rashtak; Michael W Ettore; Henry A Homburger; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-04       Impact factor: 11.382

6.  The changing clinical presentation of coeliac disease.

Authors:  M Ravikumara; D P Tuthill; H R Jenkins
Journal:  Arch Dis Child       Date:  2006-08-03       Impact factor: 3.791

7.  Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Ivor D Hill; Martha H Dirks; Gregory S Liptak; Richard B Colletti; Alessio Fasano; Stefano Guandalini; Edward J Hoffenberg; Karoly Horvath; Joseph A Murray; Mitchell Pivor; Ernest G Seidman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-01       Impact factor: 2.839

8.  Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.

Authors:  Britta Van Meensel; Martin Hiele; Ilse Hoffman; Severine Vermeire; Paul Rutgeerts; Karel Geboes; Xavier Bossuyt
Journal:  Clin Chem       Date:  2004-09-23       Impact factor: 8.327

9.  Performance of serology assays for diagnosing celiac disease in a clinical setting.

Authors:  Miriam Parizade; Yoram Bujanover; Batya Weiss; Vered Nachmias; Bracha Shainberg
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.

Authors:  Daniel Agardh
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-01       Impact factor: 11.382
View more
  6 in total

1.  Celiac disease screening assays for children younger than 3 years of age: the performance of three serological tests.

Authors:  Iva Hojsak; Yael Mozer-Glassberg; Netta Segal Gilboa; Ronit Weinberger; Corina Hartman; Raanan Shamir
Journal:  Dig Dis Sci       Date:  2011-08-17       Impact factor: 3.199

Review 2.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

Review 3.  Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.

Authors:  N Ontiveros; M Y Hardy; F Cabrera-Chavez
Journal:  Gastroenterol Res Pract       Date:  2015-04-29       Impact factor: 2.260

4.  Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!

Authors:  Michele Arigliani; Francesca Rech Morassutti; Martina Fabris; Paola Melli; Elio Tonutti; Paola Cogo
Journal:  Ital J Pediatr       Date:  2017-08-10       Impact factor: 2.638

5.  Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic Review and Meta-Analysis.

Authors:  Giulia N Catassi; Alfredo Pulvirenti; Chiara Monachesi; Carlo Catassi; Elena Lionetti
Journal:  Nutrients       Date:  2021-12-21       Impact factor: 5.717

6.  Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients.

Authors:  Sara Vallejo-Diez; David Bernardo; María de Lourdes Moreno; Alba Muñoz-Suano; Luis Fernández-Salazar; Carmen Calvo; Carolina Sousa; José A Garrote; Angel Cebolla; Eduardo Arranz
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.